每经AI快讯，9月17日，香江控股涨停走出4连板，4天累计涨幅达47.19%。 （文章来源：每日经济新闻） ...

（文章来源：证券日报） 证券日报网讯 9月16日晚间，香江控股发布公告称，公司自2025年9月12日以来，公司股票累计涨幅 30.50%，股票涨幅明显偏离同行业及上证指数，但是公司主营业务、生产经营情况以及经营环境与前 期披露的信息相比未发生重大变化。公司目前的市净率为1.338倍，根据中证指数有限公司网站发布的 中国上市公司协会分类结果显示：2025年9月15日公司所属中上协大类"房地产"的行业市净率为0.91 倍，公司市净率高于行业平均水平。公司不存在应披露而未披露的重大信息，不存在影响公司股票交易 价格异常波动的重大事项。鉴于近日公司股票剔除大盘和行业整体影响后的实际波动幅度较大，敬请广 大投资者注意二级市场交易风险，理性投资，审慎投资。 ...

Core Viewpoint - Xiangjiang Holdings (600162) experienced a trading halt today with a daily turnover rate of 2.28%, a transaction amount of 177 million yuan, and a fluctuation of 0.85% [2] Trading Data - The stock was listed on the Shanghai Stock Exchange due to a daily price deviation of 10.15%, with institutional net selling of 3.4562 million yuan and a net selling of 4.2797 million yuan from the Shanghai-Hong Kong Stock Connect [2] - The top five trading departments accounted for a total transaction amount of 135 million yuan, with a buying amount of 105 million yuan and a selling amount of 29.2414 million yuan, resulting in a net buying of 76.1777 million yuan [2] Institutional Activity - Among the trading departments, one institutional special seat was noted, which had a net selling of 3.4562 million yuan, while the Shanghai-Hong Kong Stock Connect was the third-largest selling department with a selling amount of 4.2797 million yuan [2] - The main capital flow showed a net inflow of 41.9739 million yuan, with a large single net inflow of 63.1310 million yuan and a large single capital outflow of 21.1572 million yuan over the day [2] - Over the past five days, the main capital net inflow totaled 53.9703 million yuan [2] Financial Performance - On August 28, the company released its semi-annual report, indicating a total operating income of 736 million yuan for the first half of the year, a year-on-year decrease of 61.52%, and a net profit of -19.8462 million yuan [2]

New Stock Issuance - Jin Hua New Material (920015) issued at a price of 18.15[1] - Jianfa Zhixin (301584) issued at a price of 7.05[1] Market Alerts - Cash option declaration period for *ST Tianmao (000627) from September 15 to September 19, 2025[1] - 13 trading days remaining for the delisting period of Zitian Tui (300280)[1] - Severe abnormal fluctuation reported for Jishi Media (601929)[1] Other Announcements - Multiple companies including Shanghai Construction (600170) and Zhongke Shuguang (603019) have recent announcements linked[1] - Various stocks are under scrutiny for abnormal trading activities, including *ST Yu Shun (002289) and ST Huaneng (000851)[3]

Market Performance - On September 16, the real estate development sector rose by 1.27% compared to the previous trading day, with Xiangjiang Holdings leading the gains [1] - The Shanghai Composite Index closed at 3861.87, up 0.04%, while the Shenzhen Component Index closed at 13063.97, up 0.45% [1] Individual Stock Performance - Xiangjiang Holdings (600162) closed at 2.38, with a gain of 10.19% and a trading volume of 744,400 shares, amounting to a transaction value of 177 million [1] - Shoukai Co. (600376) closed at 6.67, up 10.07%, with a trading volume of 2,225,800 shares, totaling 144.9 million [1] - Rongsheng Development (002146) closed at 2.12, increasing by 9.84%, with a trading volume of 8,621,000 shares, amounting to 1.805 billion [1] - Other notable performers include Jintou Chengkai (600322) with a 7.14% increase, and Wolong New Energy (600173) with a 6.86% increase [1] Capital Flow Analysis - The real estate development sector experienced a net outflow of 381 million from institutional investors, while retail investors saw a net inflow of 674 million [2] - The capital flow data indicates that major stocks like Xiangjiang Holdings and Shoukai Co. had significant net outflows from institutional and speculative funds [3]

Core Viewpoint - Shenzhen Xiangjiang Holdings Co., Ltd. has issued a stock trading risk warning due to a significant stock price increase of 30.50% since September 12, which deviates from industry peers and the Shanghai Composite Index, despite no changes in its main business operations [1] Financial Performance - For the fiscal year 2024, the company's net profit is approximately 61.8 million yuan, reflecting a year-on-year decline of 11.07% [1] - In the first half of 2025, the company's revenue is reported at 736.13 million yuan, showing a substantial year-on-year decrease of 61.52%, with a net loss of approximately -19.8 million yuan, marking a year-on-year decline of 147.19% [1] Valuation Metrics - The company's current price-to-book ratio stands at 1.338, which is higher than the average of 0.91 for the "real estate" industry [1]

证券代码：600162 证券简称：香江控股 公告编号：临 2025-031 深圳香江控股股份有限公司 关于股票交易风险提示的公告 公司前期披露的信息不存在需要更正、补充之处，不存在应披露而未披露的 信息；公司不存在除前期已披露事项外的影响公司股票交易价格异常波动的重大 事宜。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 深圳香江控股股份有限公司（以下简称"香江控股"、"本公司"或"公 司"）自 2025 年 9 月 12 日以来，公司股票累计涨幅 30.50%，股票涨幅明显偏离 同行业及上证指数，但是公司主营业务、生产经营情况以及经营环境与前期披露 的信息相比未发生重大变化。 公司目前的市净率为 1.338，根据中证指数有限公司网站发布的中国上 市公司协会分类结果显示：2025 年 9 月 15 日公司所属中上协大类"房地产"的 行业市净率为 0.91，公司市净率高于行业平均水平。敬请投资者理性投资，注 意二级市场交易风险。 公司不存在应披露而未披露的重大信息，不存在影响公司股票交易价格 异常波动的重 ...

Group 1 - A total of 89 stocks in the A-share market reached the daily limit up on September 16 [1] - Multiple real estate stocks experienced consecutive limit-ups, with Rongsheng Development and Xiangjiang Holdings achieving three consecutive limit-ups [1]

Group 1 - The A-share market showed a relatively sluggish performance on September 16, with the Sci-Tech Innovation 50 Index performing better, rising over 2% at one point [1][3][4] - Despite the overall market volatility, a significant number of individual stocks remained active, with many hitting the daily limit up, prompting related companies to issue risk warnings [1][6] - The Sci-Tech Innovation 50 Index saw a strong performance, with component stocks like Haiguang Information rising over 10%, reaching a market capitalization of over 580 billion [4] Group 2 - In the Hong Kong market, the Hang Seng Index opened slightly higher but turned negative during the session, with Fosun Pharma experiencing a dramatic rise of over 400% [2][13][15] - Fosun Pharma announced the approval of its "Metformin and Empagliflozin Tablets (I)" for market, which is indicated for improving blood sugar control in adult patients with type 2 diabetes [18][19]

据天眼查APP显示，深圳香江控股股份有限公司成立于1994年01月30日。注册资本326843.8122万人民 币。（数据宝） 香江控股盘中涨停，已连收3个涨停板，截至9:25，该股报2.38元，换手率0.85%，成交量2786.32万股， 成交金额6631.44万元，连续涨停期间，该股累计上涨33.71%，累计换手率为9.32%。最新A股总市值达 77.79亿元。 证券时报·数据宝统计，两融数据来看，该股最新（9月15日）两融余额为1.24亿元，其中，融资余额 1.24亿元，较前一个交易日减少338.49万元，环比下降2.65%，近3日累计减少816.70万元，环比下降 6.16%。 龙虎榜数据显示，该股因连续三个交易日内，涨幅偏离值累计达20%、日涨幅偏离值达7%上榜龙虎榜1 次，买卖居前营业部中，机构净卖出1606.51万元，沪股通累计净卖出392.51万元，营业部席位合计净买 入1633.17万元。 公司发布的半年报数据显示，上半年公司共实现营业收入7.36亿元，同比下降61.52%，实现净利 润-1984.62万元，同比下降147.19%，基本每股收益为-0.0061元。 （文章来源：证券时报网） ...